Single Dose Truvada in HIV-negative Men and Women (TAIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01326221
Recruitment Status : Completed
First Posted : March 30, 2011
Last Update Posted : October 10, 2012
Gilead Sciences
Information provided by (Responsible Party):
Angela Kashuba, PharmD, University of North Carolina, Chapel Hill

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2009
  Actual Study Completion Date : May 2009